Product
Ipratropium + Levosalbutamol Free Dose Combination
2 clinical trials
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
A Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD)Status: Recruiting, Estimated PCD: 2024-02-06
Clinical trial
Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination in pMDI Form and Ipratropium and Salbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD)Status: Active (not recruiting), Estimated PCD: 2024-06-01